within Pharmacolibrary.Drugs.ATC.A;

model A16AB23
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 12 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 2000 / 1000000,
    adminCount     = 1,
    Vd             = 0.0046,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Cipaglucosidase alfa is a recombinant human acid alpha-glucosidase (GAA) enzyme replacement therapy (ERT) indicated for the treatment of Pompe disease, a lysosomal storage disorder caused by GAA deficiency. It is currently approved for use in combination with miglustat.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters are estimated for adults with late-onset Pompe disease based on typical dosing and available regulatory documents. No peer-reviewed publications or DOIs report pharmacokinetic parameters for cipaglucosidase alfa.</p><h4>References</h4><ol><li><p>Byrne, BJ, et al., &amp; Mozaffar, T (2024). Long-term safety and efficacy of cipaglucosidase alfa plus miglustat in individuals living with Pompe disease: an open-label phase I/II study (ATB200-02). <i>Journal of neurology</i> 271(4) 1787–1801. DOI:<a href=&quot;https://doi.org/10.1007/s00415-023-12096-0&quot;>10.1007/s00415-023-12096-0</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/38057636/&quot;>https://pubmed.ncbi.nlm.nih.gov/38057636</a></p></li><li><p>Byrne, BJ, et al., &amp; Mozaffar, T (2024). Cipaglucosidase alfa plus miglustat: linking mechanism of action to clinical outcomes in late-onset Pompe disease. <i>Frontiers in neurology</i> 15 1451512–None. DOI:<a href=&quot;https://doi.org/10.3389/fneur.2024.1451512&quot;>10.3389/fneur.2024.1451512</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/39494167/&quot;>https://pubmed.ncbi.nlm.nih.gov/39494167</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end A16AB23;
